Publications by authors named "Niklas Czeloth"

Claim this Profile
S
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study.
Alan Menter, Petr Arenberger, Sigrid Balser, Stefan Beissert, Ashley Cauthen, Niklas Czeloth

Expert Opin Biol Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext).
Stanley B Cohen, Niklas Czeloth, Eric Lee, Piotr A Klimiuk, Nuala Peter

Expert Opin Biol Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects.
Willem Hettema, Christopher Wynne, Benjamin Lang, Mario Altendorfer, Niklas Czeloth

Expert Opin Investig Drugs· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects.
Christopher Wynne, Mario Altendorfer, Ivo Sonderegger, Lien Gheyle, Rod Ellis-Pegler, Niklas Czeloth

Expert Opin Investig Drugs· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64(+) cells.
Stephanie Vogel, Elena Grabski, Daniela Buschjäger, Frank Klawonn, Marius Döring, Niklas Czeloth

Sci Rep· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway.
Bianca Helling, Martin König, Benjamin Dälken, Andre Engling, Wolfgang Krömer, Niklas Czeloth

Immunol Cell Biol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells.
Sebastian Seth, Quan Qiu, Simon Danisch, Michael K Maier, Asolina Braun, Niklas Czeloth

J Biol Chem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration.
Anchana Rathinasamy, Niklas Czeloth, Oliver Pabst, Reinhold Förster, Günter Bernhardt

J Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.
Christian Koenecke, Niklas Czeloth, Anja Bubke, Susanne Schmitz, Adrien Kissenpfennig

Eur J Immunol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells.
Sebastian Seth, Anna-Maria Georgoudaki, Benedict J Chambers, Quan Qiu, Elisabeth Kremmer, Niklas Czeloth

J Leukoc Biol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytohesin-1 controls the activation of RhoA and modulates integrin-dependent adhesion and migration of dendritic cells.
Thomas Quast, Barbara Tappertzhofen, Cora Schild, Jessica Grell, Niklas Czeloth

Blood· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen.
Niklas Czeloth, Angela Schippers, Norbert Wagner, Werner Müller, Birgit Küster

J Immunol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens.
Michael K Maier, Sebastian Seth, Niklas Czeloth, Quan Qiu, Inga Ravens

Eur J Immunol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine.
Meike Wendland, Niklas Czeloth, Nicolas Mach, Bernard Malissen, Elisabeth Kremmer

Proc Natl Acad Sci U S A· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingosine-1-phosphate mediates migration of mature dendritic cells.
Niklas Czeloth, Günter Bernhardt, Fred Hofmann, Harald Genth, Reinhold Förster

J Immunol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting edge: egress of newly generated plasma cells from peripheral lymph nodes depends on beta 2 integrin.
Oliver Pabst, Thorsten Peters, Niklas Czeloth, Günter Bernhardt, Karin Scharffetter-Kochanek

J Immunol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.
Lars Ohl, Mariette Mohaupt, Niklas Czeloth, Gabriele Hintzen, Ziba Kiafard

Immunity· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis